Relief Cardiovascular
Developer of a new implantable device designed to treat congestive heart failure. The company's device monitors and modulates blood flow and is intended to reduce congestion in the heart and potential...
Valuation
$24.5M
Market implied
Share Price
N/A
Total Raised
$13.5M
Last Round
N/A